Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy-Reference-Cited by-同舟云学术

Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy

Author:

Sun Feng-Kai¹,Sun Qi²,Fan Yu-Chen¹³,Gao Shuai¹,Zhao Jing¹,Li Feng¹,Jia Yi-Bin⁴,Liu Chuan⁵,Wang Li-Yuan¹,Li Xin-You¹,Ji Xiang-Fen¹,Wang Kai¹³

Affiliation:

1. Department of Hepatology; Qilu Hospital of Shandong University; Jinan China

2. Department of Hepatobiliary Surgery; Qilu Hospital of Shandong University; Jinan China

3. Institute of Hepatology; Shandong University; Jinan China

4. Department of Oncology; Qilu Hospital of Shandong University; Jinan China

5. Department of General Surgery; Qilu Hospital of Shandong University; Jinan China

Funder

Key Project of Chinese Ministry of Science and Technology

National Natural Science Foundation of China

Science and Technology Development Plan of Shandong Province

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

Reference32 articles.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献